CompoAtlas

Probaclac K

Natural health product licensed in Canada

Licence holder
Les laboratoires Nicar inc.
NPN or DIN-HM
80083662
Status
Active licence
Licence date
7 March 2018
Revision date
22 December 2020
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lacticaseibacillus rhamnosus

Source : A008

1 Milliards d'UFCNot calculated
Lacticaseibacillus rhamnosus

Source : Cellule entière

1 Milliards d'UFCNot calculated
Lactobacillus reuteri

Source : A113

100 Millions d'UFCNot calculated
Lactobacillus reuteri

Source : Cellule entière

100 Millions d'UFCNot calculated
Lactobacillus acidophilus

Source : Cellule entière

300 %Not calculated
Lactobacillus acidophilus

Source : A118

300 %Not calculated
Bifidobacterium longum subsp. infantis

Source : A041

300 %Not calculated
Bifidobacterium longum subsp. infantis

Source : Cellule entière

300 %Not calculated
Bifidobacterium longum subsp. infantis

Source : A041

300 Millions d'UFCNot calculated
Bifidobacterium longum subsp. infantis

Source : Cellule entière

300 Millions d'UFCNot calculated
Bifidobacterium bifidum

Source : Cellule entière

300 %Not calculated
Bifidobacterium bifidum

Source : A058

300 %Not calculated
Lacticaseibacillus rhamnosus

Source : A008

300 %Not calculated
Lacticaseibacillus rhamnosus

Source : Cellule entière

300 %Not calculated
Lactobacillus reuteri

Source : A113

300 %Not calculated
Lactobacillus reuteri

Source : Cellule entière

300 %Not calculated
Bifidobacterium bifidum

Source : Cellule entière

300 Millions d'UFCNot calculated
Bifidobacterium bifidum

Source : A058

300 Millions d'UFCNot calculated

Non-medicinal ingredients

Hypromellose, Stéarate de magnésium, Inuline, Dioxyde de titane, Maltodextrine, Acide ascorbique

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 1 year1 Capsule1 Tous les jours

Uses authorised in Canada

Aide à contrôler la diarrhée infectieuse aiguë. Contribue à soutenir la santé intestinale/gastrointestinale chez l'enfant.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80083662

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line